-
-
-
-
-
-
-
Innoviva Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
-
-
-
-
-
-
-
Innoviva Announces FDA Advisory Committee Meeting to Review Sulbactam-Durlobactam (SUL-DUR), an Investigational Targeted Antibiotic
-
-
-
15,627 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

